Katherine A High - Net Worth and Insider Trading

Katherine A High Net Worth

The estimated net worth of Katherine A High is at least $24 Million dollars as of 2022-11-29. Katherine A High is the See Remarks of Spark Therapeutics Inc and owns about 210,000 shares of Spark Therapeutics Inc (ONCE) stock worth over $24 Million. Details can be seen in Katherine A High's Latest Holdings Summary section.

Transaction Summary of Katherine A High

To

Katherine A High Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Katherine A High owns 3 companies in total, including CRISPR Therapeutics AG (CRSP) , Incyte Corp (INCY) , and Spark Therapeutics Inc (ONCE) .

Click here to see the complete history of Katherine A High’s form 4 insider trades.

Insider Ownership Summary of Katherine A High

Ticker Comapny Transaction Date Type of Owner
CRSP CRISPR Therapeutics AG 2019-06-11 director
INCY Incyte Corp 2020-03-26 director
ONCE Spark Therapeutics Inc 2019-12-17 director & See Remarks

Katherine A High Latest Holdings Summary

Katherine A High currently owns a total of 1 stock. Katherine A High owns 210,000 shares of Spark Therapeutics Inc (ONCE) as of November 28, 2017, with a value of $24 Million.

Latest Holdings of Katherine A High

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ONCE Spark Therapeutics Inc 2017-11-28 210,000 113.57 23,849,700

Holding Weightings of Katherine A High


Katherine A High Form 4 Trading Tracker

According to the SEC Form 4 filings, Katherine A High has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 5,000 shares on November 28, 2017, which brought Katherine A High around $356,600.

Insider Trading History of Katherine A High

Ticker Company Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Current Price Price Change Since Insider Trade (%) Filing Date
ONCE
Spark Therapeutics Inc
2017-11-28 Sell
5,000.00
-2.33%
$71.32
$356,600.00
210,000.00
$113.57
59.24%
-
ONCE
Spark Therapeutics Inc
2017-10-31 Sell
5,000.00
-2.33%
$83.30
$416,500.00
210,000.00
$113.57
36.34%
-
ONCE
Spark Therapeutics Inc
2017-09-26 Sell
5,000.00
-2.33%
$86.16
$430,800.00
210,000.00
$113.57
31.81%
-
ONCE
Spark Therapeutics Inc
2017-08-29 Sell
10,000.00
-4.55%
$80.25
$802,500.00
210,000.00
$113.57
41.52%
-
ONCE
Spark Therapeutics Inc
2017-07-25 Sell
10,000.00
-4.55%
$72.53
$725,300.00
210,000.00
$113.57
56.58%
-
ONCE
Spark Therapeutics Inc
2017-06-27 Sell
10,000.00
-4.55%
$60.96
$609,600.00
210,000.00
$113.57
86.30%
-
ONCE
Spark Therapeutics Inc
2017-06-19 Sell
10,000.00
-4.55%
$60.00
$600,000.00
210,000.00
$113.57
89.28%
-
ONCE
Spark Therapeutics Inc
2017-04-28 Sell
15,000.00
-6.67%
$58.06
$870,900.00
210,000.00
$113.57
95.61%
-
ONCE
Spark Therapeutics Inc
2017-04-25 Sell
15,000.00
-6.67%
$55.33
$829,950.00
210,000.00
$113.57
105.26%
-
ONCE
Spark Therapeutics Inc
2016-11-14 Sell
10,000.00
-4.55%
$60.30
$603,000.00
210,000.00
$113.57
88.34%
-
ONCE
Spark Therapeutics Inc
2016-09-15 Sell
10,000.00
-4.35%
$60.37
$603,700.00
220,000.00
$113.57
88.12%
-
ONCE
Spark Therapeutics Inc
2016-08-15 Sell
10,000.00
-4.17%
$62.76
$627,600.00
230,000.00
$113.57
80.96%
-
ONCE
Spark Therapeutics Inc
2016-08-10 Sell
1,890.00
-0.78%
$60.00
$113,400.00
240,000.00
$113.57
89.28%
-
ONCE
Spark Therapeutics Inc
2016-08-03 Sell
17,610.00
-6.77%
$60.02
$1,056,950.00
242,390.00
$113.57
89.22%
-
ONCE
Spark Therapeutics Inc
2016-05-24 Sell
10,000.00
-3.70%
$54.00
$540,000.00
260,000.00
$113.57
110.31%
-
ONCE
Spark Therapeutics Inc
2016-05-23 Sell
10,000.00
-3.57%
$54.42
$544,200.00
270,000.00
$113.57
108.69%
-
ONCE
Spark Therapeutics Inc
2015-12-01 Sell
10,000.00
-3.45%
$55.31
$553,100.00
280,000.00
$113.57
105.33%
-
ONCE
Spark Therapeutics Inc
2015-11-16 Sell
10,000.00
-3.33%
$53.77
$537,700.00
290,000.00
$113.57
111.21%
-
ONCE
Spark Therapeutics Inc
2015-10-14 Sell
40,000.00
-11.76%
$49.01
$1,960,400.00
300,000.00
$113.57
131.73%
-
Total 19
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Katherine A High Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Katherine A High Ownership Network

Ownership Network List of Katherine A High

No Data

Ownership Network Relation of Katherine A High


Katherine A High Owned Company Details


Katherine A High Mailing Address

Above is the net worth, insider trading, and ownership report for Katherine A High. You might contact Katherine A High via mailing address: 3737 Market Street, Suite 1300, Philadelphia Pa 19104.